Residual Nodal Burden After Neoadjuvant Systemic Therapy in N2-N3 Her2+ and Triple Negative Breast Cancer

Triple-negative breast cancer Neoadjuvant Therapy Systemic therapy
DOI: 10.1016/j.ejso.2023.107435 Publication Date: 2024-02-23T23:55:53Z